Pandemic is a Mixed Bag for $30 Billion Sleep Aids Market

Pandemic is a Mixed Bag for $30 Billion Sleep Aids Market

June 3, 2021

Marketdata Releases New Report on the Sleep Aids Market

As obesity rates climb and Americans age, more people are developing sleep apnea, restless leg syndrome and other sleep disorders. Plus, stress in 2020 related to the presidential election, Covid-19 pandemic and recession are all contributing to more sleepless nights. As a result, a huge industry has emerged to analyze and treat America’s insomniacs—sleep labs and home test devices, CPAP masks, premium mattresses and pillows, Rx and OTC sleep medications, apps, sound machines and more.

Major Findings:

  • Market Size and Growth… Marketdata estimates that the U.S. sleep market was worth $30.6 billion in 2019, up 3.0% from the prior year. The market barely inched up 0.1% in value, to $30.7 billion in 2020, but the total market is forecast to grow 4.8% this year, to a value of $32.1 billion.
  • Prescription insomnia drugs…This market, led by Belsomra, Ambien, and Lunesta, has been declining in value due to the expiration of patents and the entry of cheaper generics. However, OTC supplement sales are growing strongly. The total market of Rx and OTC sleep “drugs” is estimated at $2.1 billion in 2020.
  • Sleep Centers… There was a major shift in the mix of in-center vs. cheaper at-home sleep studies performed by sleep centers during 2020—from 70% in-house/30% at-home to 30% in-house/70% at-home. This shift to telemedicine, coupled with center closures and lower patient volumes, caused revenues to fall by 27%, to $3.1 billion. A rebound is forecast in 2021. There are an estimated 4,400 U.S. sleep labs.
  • CPAP devices – A significant market segment and the one with the highest current growth rates is the CPAP devices market—continuous positive airway pressure devices used for persons with obstructive sleep apnea. This industry remains less than 12% penetrated in the U.S. The market was worth $6.47 billion in 2020, representing a strong 15% gain. Part of this gain was due to strong orders for ventilators last year.
  • Mattress Market… With consumers more focused than ever last year on comfort and improving their sleep quality, mattress sales held up well, growing by 1.2% to $16.9 billion in retail sales. This market is being disrupted by makers such as Casper and Purple, that have ditched the retail showroom and deliver directly to the customer’s home.
  • The sleep pillows market is worth $1.88 billion and is also growing, as new materials and premium-priced and “smart” pillows enter the market.

For More Information About The Sleep Market…

See: for a detailed Table of Contents and report description: The U.S. Sleep Market: Sleep Labs, Bedding, CPAPs, Drugs & More.  This May 2021 report is 177 pp. long and contains in-depth analyses of: the U.S. mattress & pillows market, CPAP market, sleep labs industry, insomnia drugs market, and retail sleep devices market, with 10 competitor profiles, 40+ table & charts. The complete report (FS 34) sells for $1,495, but single chapters can be purchased at lower cost. Also, a 37-page Overview (OV 37  ) is available for $99. Questions? Call us at: 813-971-8080.